~~<i id='9004AF1336'><strike id='9004AF1336'><tt id='9004AF1336'><pre id='9004AF1336'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

leisure time

author：fashion 2025-10-01 20:14:19 - browse：36781

An illustration of red blood cells — Adobe

As a boy growing up with hemophilia A, Noah Frederick reserved the end of his annual checkups to talk about new technologies. His doctor walked through various experimental approaches for the bleeding disorder and, invariably, gene therapy. It was coming, he always said, in your lifetime.

Last year, it finally arrived. But Frederick, now a 23-year-old software engineer, isn’t sure he’ll get it. He wants to be part of the sci-fi future gene therapy has always represented, but a recent doctor’s visit left him uncertain.

“I’m on the fence,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： How I ended up pumping milk in a bathroom stall at JPM 2024

focus

hotspot

explore

hotspot

focus

entertainment

ErikaCheungandTylerShultzDanielBoczarski/GettyImagesforNewYorkMagazineShejoinedTheranosfreshoutofthe

WSS

A strong 6.5

Heart disease and mental health: A look at cardiac psychology

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Risky weight loss products often used by teens globally, per study

UK homeowners get some respite as inflation falls by more than anticipated to a 15

A look at other Americans who have crossed into North Korea over the years

Wikipedia

leisure time

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Generative AI mines health records to identify patients’ social needs

New air purifier tech could be key to improving indoor air quality

The nurse manager staffing crisis is hurting patients

United colonoscopy coverage change 'may cost lives,' doctors say

House passes resolution saying Israel isn't a 'racist or apartheid state'

How one medical school became remarkably diverse

Why you get paid to donate plasma but not blood

BioMarin wins approval for gene therapy to treat hemophilia A

HHS names first

hotspot

ER docs worry over extreme heat as a 'mass casualty event'

As JPM 2024 winds down, some health tech firms project optimism

Flagship, Pfizer team up in deal worth up to $7 billion

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

explore

hotspot

focus

entertainment